Pembrolizumab as a promising treatment in patients with classic or endemic Kaposi’s sarcoma
1. Treatment with pembrolizumab yielded a best overall response rate of 71%. 2. Adverse events occurred in 76% of patients, ...
1. Treatment with pembrolizumab yielded a best overall response rate of 71%. 2. Adverse events occurred in 76% of patients, ...
Immunotherapies such as anti-PD-1 (anti-programmed cell death 1) and anti-PD-L1 (anti-programmed cell death ligand 1) are effective in treating numerous ...
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.